Cytek Biosciences (CTKB) Short-Term Debt issuances (2024 - 2026)

Cytek Biosciences (CTKB) has 3 years of Short-Term Debt issuances data on file, last reported at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Short-Term Debt issuances rose 211.11% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.5 million (up 100.65% YoY), and the FY2025 full-year result was $5.6 million, up 33.51% from the prior year.
• Short-Term Debt issuances for Q1 2026 stood at $1.4 million, roughly flat from $1.4 million in the prior quarter.
• Across five years, Short-Term Debt issuances topped out at $2.8 million in Q4 2024 and bottomed at -$3000.0 in Q2 2024.
• The 3-year median for Short-Term Debt issuances is $1.4 million (2025), against an average of $1.2 million.
• Peak annual rise in Short-Term Debt issuances reached 54266.67% in 2025, while the deepest fall reached 67.72% in 2025.
• A 3-year view of Short-Term Debt issuances shows it stood at $2.8 million in 2024, then sank by 50.0% to $1.4 million in 2025, then changed by 0.0% to $1.4 million in 2026.
• The last three Short-Term Debt issuances figures came in at $1.4 million (Q1 2026), $1.4 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.

Peer Comparison